Presentation given as part of the panel at GCV Symposium London 23 May 2017
Panel included Bill Taranto Merck Global Health Innovation
Jacqueline Lesage-Krause MunichRE
David Mayhew GE Ventures
Geoff McGrath McLaren Applied Technologies
Andrew Gaule Aimava and GCV Academy